The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 338:286-290 January 29, 1998 Number 5
NextNext

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C
Sandro Vento, M.D., Tiziana Garofano, M.D., Carlo Renzini, M.D., Francesca Cainelli, M.D., Ferruccio Casali, M.D., Giancarlo Ghironzi, M.D., Teresa Ferraro, M.D., and Ercole Concia, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Hepatitis A virus (HAV) infection rarely causes fulminant hepatic failure in people with no underlying liver disease. There are limited data on the course of this infection in patients with chronic hepatitis B and chronic hepatitis C.

Methods We prospectively followed, from June 1990 to July 1997, 595 adults with biochemical and histologic evidence of chronic hepatitis B (163 patients) or chronic hepatitis C (432 patients) who were seronegative for HAV antibodies. All were tested every four months for serum IgM and IgG antibodies to HAV.

Results Twenty-seven patients acquired HAV superinfection, 10 of whom had chronic hepatitis B and 17 of whom had chronic hepatitis C. One of the patients with chronic hepatitis B, who also had cirrhosis, had marked cholestasis (peak serum bilirubin level, 28 mg per deciliter [479 µmol per liter]); the other nine had uncomplicated courses of hepatitis A. Fulminant hepatic failure developed in seven of the patients with chronic hepatitis C, all but one of whom died. The other 10 patients with chronic hepatitis C had uncomplicated courses of hepatitis A.

Conclusions Although most patients with chronic hepatitis B who acquired HAV infection had an uncomplicated course, patients with chronic hepatitis C had a substantial risk of fulminant hepatitis and death associated with HAV superinfection. Our data suggest that patients with chronic hepatitis C should be vaccinated against hepatitis A.


Source Information

From the Department of Infectious Diseases, University of Verona, Verona, Italy (S.V., F. Cainelli, E.C.); the Infectious Diseases Unit, A. Pugliese Hospital, Catanzaro, Italy (T.G., T.F.); and the Department of Internal Medicine (C.R., G.G.) and Central Laboratory (F. Casali), San Marino State Hospital, San Marino, Republic of San Marino.

Address reprint requests to Dr. Vento at the Department of Infectious Diseases, University of Verona, via Locchi, 12, 37124 Verona, Italy.

Full Text of this Article


Related Letters:

Hepatitis Associated with Hepatitis A Superinfection in Patients with Chronic Hepatitis C
Mele A., Tosti M. E., Stroffolini T., Battegay M., Naef M., Bucher H. C., Leino T., Pebody R., Leinikki P., Martins E. B., Vento S., Concia E., Ghironzi G.
Extract | Full Text  
N Engl J Med 1998; 338:1771-1773, Jun 11, 1998. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.